Merck KGaA

Merck KGaA signs another AI deal
Merck KGaA signs another AI deal
Pharmaforum
Merck KGaA
artificial intelligence
Iktos
drug discovery
Flag link:
Merck KGaA admits to ‘challenging’ 2018, as currencies hit sales
Merck KGaA admits to ‘challenging’ 2018, as currencies hit sales
Pharmaforum
Merck KGaA
earnings
Flag link:
After Tesaro buy, GSK wades deeper into cancer unveiling big immunotherapy deal with Germany's Merck
After Tesaro buy, GSK wades deeper into cancer unveiling big immunotherapy deal with Germany's Merck
Endpoints
GSK
Merck KGaA
Tesaro
immunotherapy
Flag link:
Forget the suggestion box. Merck KGaA puts employee ideas on a TED stage
Forget the suggestion box. Merck KGaA puts employee ideas on a TED stage
Fierce Pharma
Merck KGaA
pharma employees
TED talks
Flag link:
Merck KGaA signs China digital health deal with Tencent
Merck KGaA signs China digital health deal with Tencent
Pharmaforum
Merck KGaA
Tencent
China
digital healthcare
artificial intelligence
Flag link:
Vertex sharpens focus on gene-editing in licensing deal with Merck KGaA
Vertex sharpens focus on gene-editing in licensing deal with Merck KGaA
Endpoints
Vertex Pharmaceuticals
Merck KGaA
gene editing
M9831
Flag link:
Bavencio fails second ovarian cancer Phase III trial
Bavencio fails second ovarian cancer Phase III trial
BioCentury
Merck KGaA
Bavencio
ovarian cancer
Flag link:
Merck KGaA hands off its CAR-T R&D operations to Intrexon in $175M deal
Merck KGaA hands off its CAR-T R&D operations to Intrexon in $175M deal
Endpoints
Merck KGaA
CAR-T
Intrexion
M&A
Flag link:
Merck's Keytruda puts heat on Pfizer, Merck KGaA's Bavencio with new Merkel cell OK
Merck's Keytruda puts heat on Pfizer, Merck KGaA's Bavencio with new Merkel cell OK
Fierce Pharma
Merck
Keytruda
Pfizer
Merck KGaA
Bavencio
Merkel cell carcinoma
Flag link:
Merck KGaA links with AI firm to iron out side-effects during R&D
Merck KGaA links with AI firm to iron out side-effects during R&D
Pharmaforum
Merck KGaA
R&D
artificial intelligence
Cyclica
drug development
Flag link:
Merck KGaA Partners With Startup for Image Tagging Software
Merck KGaA Partners With Startup for Image Tagging Software
Yahoo/Bloomberg
Merck KGaA
V7
artificial intelligence
Flag link:
Syntropy, a Merck KGaA – Palantir JV aiming to apply big data to cancer research
Syntropy, a Merck KGaA – Palantir JV aiming to apply big data to cancer research
GoinPharma
Merck KGaA
Palantir Technologies
Syntropy
cancer
Big Data
Flag link:
A Small Group of Pharma Companies Is Making the Bulk of Medicines Necessary for Developing Countries
A Small Group of Pharma Companies Is Making the Bulk of Medicines Necessary for Developing Countries
BioSpace
GSK
JNJ
Novartis
Merck KGaA
Sanofi
Takeda
developing countries
Flag link:
Merck KGaA Enters Field of Big Data With Joint Venture With Palantir Technologies
Merck KGaA Enters Field of Big Data With Joint Venture With Palantir Technologies
BioSpace
Big Data
Merck KGaA
Palantir Technologies
Syntropy
cancer
Flag link:
Merck KGaA and Pfizer say drug failed to meet primary endpoints in late-stage ovarian cancer trial
Merck KGaA and Pfizer say drug failed to meet primary endpoints in late-stage ovarian cancer trial
Marketwatch
Merck KGaA
Pfizer
avelumab
ovarian cancer
clinical trials
Flag link:
Immunicum Announces Collaboration with Merck KGaA and Pfizer to Evaluate Cell Therapy Treatment in Combination with Avelumab
Immunicum Announces Collaboration with Merck KGaA and Pfizer to Evaluate Cell Therapy Treatment in Combination with Avelumab
CP Wire
Immunicum
immuno-oncology
Merck KGaA
Pfizer
avelumab
Flag link:
Merck KGaA’s bold new approach to cancer immunotherapy
Merck KGaA’s bold new approach to cancer immunotherapy
Pharmaforum
Merck KGaA
cancer immunotherapy
M7824
Flag link:
Merck KGaA says might strike partnership deal this year
Merck KGaA says might strike partnership deal this year
Yahoo/Reuters
Merck KGaA
R&D
Flag link:
Merck KGaA posts mixed data from their big PhIIb MS study on evobrutinib — spurring plenty of questions
Merck KGaA posts mixed data from their big PhIIb MS study on evobrutinib — spurring plenty of questions
Endpoints
Merck KGaA
evobrutinib
MS
multiple sclerosis
Flag link:
Merck KGaA, Pfizer's immuno-drug shown to alleviate kidney cancer
Merck KGaA, Pfizer's immuno-drug shown to alleviate kidney cancer
Yahoo/Reuters
Merck KGaA
Bavencio
Pfizer
kidney cancer
Inlyta
Flag link:

Pages